Cargando…

Anti-Neuroinflammatory Effects of the Human Milk Oligosaccharide, 2′-Fucosyllactose, Exerted via Modulation of M2 Microglial Activation in a Mouse Model of Ischemia–Reperfusion Injury

Cerebral ischemic stroke is one of the leading causes of death and disability worldwide. 2′-fucosyllactose (2′-FL), a human milk oligosaccharide, exerts anti-inflammatory effects and plays a protective role in arterial thrombosis; however, its role in ischemic stroke remains unclear. This study aime...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pak, Malk Eun, Kim, Yeon-Ji, Kim, Hanhae, Shin, Chul Soo, Yoon, Jong-Won, Jeon, Seon-min, Song, Young-Ha, Kim, Kyungho
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10295539/ https://www.ncbi.nlm.nih.gov/pubmed/37372011 http://dx.doi.org/10.3390/antiox12061281

Ejemplares similares

The Human Milk Oligosaccharide 2'-Fucosyllactose Shows an Immune-Enhancing Effect in a Cyclophosphamide-Induced Mouse Model
por: Jo, Seon Ha, et al.
Publicado: (2023)

Production of a human milk oligosaccharide 2′-fucosyllactose by metabolically engineered Saccharomyces cerevisiae
por: Yu, Sora, et al.
Publicado: (2018)

Human Milk Oligosaccharide 2′-Fucosyllactose Induces Neuroprotection from Intracerebral Hemorrhage Stroke
por: Hung, Tsai-Wei, et al.
Publicado: (2021)

Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensal
por: James, Kieran, et al.
Publicado: (2019)

Quantifying the human milk oligosaccharides 2’‐fucosyllactose and 3‐fucosyllactose in different food applications by high‐performance liquid chromatography with refractive index detection
por: Christensen, Anne Støvlbæk, et al.
Publicado: (2020)

Review of the Clinical Experiences of Feeding Infants Formula Containing the Human Milk Oligosaccharide 2′-Fucosyllactose
por: Reverri, Elizabeth J., et al.
Publicado: (2018)

The Role of Two Human Milk Oligosaccharides, 2′-Fucosyllactose and Lacto-N-Neotetraose, in Infant Nutrition
por: Hegar, Badriul, et al.
Publicado: (2019)

Restraint stress induced gut dysmotility is diminished by a milk oligosaccharide (2′-fucosyllactose) in vitro
por: Farhin, Sohana, et al.
Publicado: (2019)

2′-Fucosyllactose and 3-Fucosyllactose Alleviates Interleukin-6-Induced Barrier Dysfunction and Dextran Sodium Sulfate-Induced Colitis by Improving Intestinal Barrier Function and Modulating the Intestinal Microbiome
por: Kim, Yeon-Ji, et al.
Publicado: (2023)

Human Milk Oligosaccharides: 2′-Fucosyllactose (2′-FL) and Lacto-N-Neotetraose (LNnT) in Infant Formula
por: Vandenplas, Yvan, et al.
Publicado: (2018)

Author Correction: Metabolism of the predominant human milk oligosaccharide fucosyllactose by an infant gut commensal
por: James, Kieran, et al.
Publicado: (2020)

Human Milk Oligosaccharide 2′-Fucosyllactose Improves Innate and Adaptive Immunity in an Influenza-Specific Murine Vaccination Model
por: Xiao, Ling, et al.
Publicado: (2018)

Human Milk Oligosaccharide 2′-Fucosyllactose Inhibits Ligand Binding to C-Type Lectin DC-SIGN but Not to Langerin
por: Mukherjee, Reshmi, et al.
Publicado: (2022)

Influence of 2′-fucosyllactose and galacto-oligosaccharides on the growth and adhesion of Streptococcus mutans
por: Salli, K., et al.
Publicado: (2020)

Human milk oligosaccharide 2′-fucosyllactose supplementation improves gut barrier function and signaling in the vagal afferent pathway in mice
por: Lee, Sunhye, et al.
Publicado: (2021)

Human milk oligosaccharide 2'-fucosyllactose promotes melanin degradation via the autophagic AMPK–ULK1 signaling axis
por: Heo, Hyojin, et al.
Publicado: (2022)

Novel Genes and Metabolite Trends in Bifidobacterium longum subsp. infantis Bi-26 Metabolism of Human Milk Oligosaccharide 2′-fucosyllactose
por: Zabel, Bryan, et al.
Publicado: (2019)

Growth, Tolerance, and Compliance of Infants Fed an Extensively Hydrolyzed Infant Formula with Added 2′-FL Fucosyllactose (2′-FL) Human Milk Oligosaccharide
por: Ramirez-Farias, Carlett, et al.
Publicado: (2021)

Human milk oligosaccharide 2’-fucosyllactose links feedings at 1 month to cognitive development at 24 months in infants of normal and overweight mothers
por: Berger, Paige K., et al.
Publicado: (2020)

Human Milk Oligosaccharide 2′-Fucosyllactose Modulates Local Viral Immune Defense by Supporting the Regulatory Functions of Intestinal Epithelial and Immune Cells
por: Ayechu-Muruzabal, Veronica, et al.
Publicado: (2022)

Author Correction: Human milk oligosaccharide 2'-fucosyllactose promotes melanin degradation via the autophagic AMPK–ULK1 signaling axis
por: Heo, Hyojin, et al.
Publicado: (2022)

Whole cell biosynthesis of a functional oligosaccharide, 2′-fucosyllactose, using engineered Escherichia coli
por: Lee, Won-Heong, et al.
Publicado: (2012)

The human milk oligosaccharides 2’-Fucosyllactose and 6’-Sialyllactose protect against the development of necrotizing enterocolitis by inhibiting Toll-Like Receptor 4 signaling.
por: Sodhi, Chhinder P., et al.
Publicado: (2020)

The oligosaccharides 6’-sialyllactose, 2’-fucosyllactose or galactooligosaccharides do not directly modulate human dendritic cell differentiation or maturation
por: Perdijk, Olaf, et al.
Publicado: (2018)

Infant Fecal Fermentations with Galacto-Oligosaccharides and 2′-Fucosyllactose Show Differential Bifidobacterium longum Stimulation at Subspecies Level
por: Lindner, Cordula, et al.
Publicado: (2023)

Eupatilin exerts neuroprotective effects in mice with transient focal cerebral ischemia by reducing microglial activation
por: Sapkota, Arjun, et al.
Publicado: (2017)

The Combination of 2′-Fucosyllactose with Short-Chain Galacto-Oligosaccharides and Long-Chain Fructo-Oligosaccharides that Enhance Influenza Vaccine Responses Is Associated with Mucosal Immune Regulation in Mice
por: Xiao, Ling, et al.
Publicado: (2019)

Upregulation of Neuronal Cylindromatosis Expression is Essential for Electroacupuncture-Mediated Alleviation of Neuroinflammatory Injury by Regulating Microglial Polarization in Rats Subjected to Focal Cerebral Ischemia/Reperfusion
por: Lin, Xing, et al.
Publicado: (2021)

The Human Milk Oligosaccharide 2′-Fucosyllactose Alleviates Liver Steatosis, ER Stress and Insulin Resistance by Reducing Hepatic Diacylglycerols and Improved Gut Permeability in Obese Ldlr-/-.Leiden Mice
por: Gart, Eveline, et al.
Publicado: (2022)

Prenylated Flavonoids from Cudrania tricuspidata Suppress Lipopolysaccharide-Induced Neuroinflammatory Activities in BV2 Microglial Cells
por: Kim, Dong-Cheol, et al.
Publicado: (2016)

Multi‐level metabolic engineering of Escherichia coli for high‐titer biosynthesis of 2′‐fucosyllactose and 3‐fucosyllactose
por: Li, Mengli, et al.
Publicado: (2022)

Effects of Paeonol on Anti-Neuroinflammatory Responses in Microglial Cells
por: Lin, Chingju, et al.
Publicado: (2015)

Ibrutinib suppresses LPS-induced neuroinflammatory responses in BV2 microglial cells and wild-type mice
por: Nam, Hye Yeon, et al.
Publicado: (2018)

Neuroprotective and Anti-Neuroinflammatory Properties of Vignae Radiatae Semen in Neuronal HT22 and Microglial BV2 Cell Lines
por: Jeong, Yun Hee, et al.
Publicado: (2022)

Anti-neuroinflammatory effects of alkaloid-enriched extract from Huperzia serrata on lipopolysaccharide-stimulated BV-2 microglial cells
por: Dang, Thu Kim, et al.
Publicado: (2023)

Synthetic 3′,4′-Dihydroxyflavone Exerts Anti-Neuroinflammatory Effects in BV2 Microglia and a Mouse Model
por: Kim, Namkwon, et al.
Publicado: (2018)

The flavonoid agathisflavone modulates the microglial neuroinflammatory response and enhances remyelination
por: de Almeida, Monique Marylin Alves, et al.
Publicado: (2020)

Immunomodulatory and Prebiotic Effects of 2′-Fucosyllactose in Suckling Rats
por: Azagra-Boronat, Ignasi, et al.
Publicado: (2019)

The Milk Active Ingredient, 2′-Fucosyllactose, Inhibits Inflammation and Promotes MUC2 Secretion in LS174T Goblet Cells In Vitro
por: Yao, Qianqian, et al.
Publicado: (2023)

Epithelial-derived galectin-9 containing exosomes contribute to the immunomodulatory effects promoted by 2’-fucosyllactose and short-chain galacto- and long-chain fructo-oligosaccharides
por: Ayechu-Muruzabal, Veronica, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_tnq9gtnp66k3qegbr4melcb2tf